Results 91 to 100 of about 51,297 (232)
Safety considerations of gene‐based therapies for Alzheimer's disease
Abstract Gene‐based therapies show increasing promise for the treatment of neurologic disease. In 2016, nusinersen, an RNA‐based therapy, was approved for children with spinal muscular atrophy (SMA). Over 200 clinical trials have utilized gene therapy approaches for a host of neurodegenerative and neuromuscular disorders, including Alzheimer's disease (
Elizabeth A. Bevins +7 more
wiley +1 more source
Posterior fossa syndrome in a patient with an ornithine transcarbamylase deficiency
The posterior fossa syndrome (PFS) is a well-known clinical entity and mainly occurs in children. Ornithine transcarbamylase deficiency (OTC) is the most common urea cycle disorder, which occurs in an estimated 1 per 50.000 live births in Japan. Symptoms
De Klerk, H. +9 more
core +1 more source
infection in a patient with ornithine transcarbamylase deficiency and liver transplant
Rapidly growing mycobacteria, including Mycobacterium abscessus, have become a common cause of post-procedural infections and are notoriously difficult to diagnose and treat.
Fabrizio V. Galimberti +7 more
core +1 more source
Ornithine transcarbamylase deficiency represents the most common inherited defect of the urea cycle. This enzyme, predominantly found in the liver, plays a crucial role in recycling free ammonia, with deficiencies often leading to fatal complications ...
M. Ramanathan, S. Uppalapu, N. Patel
semanticscholar +1 more source
ABSTRACT Arginase 1 deficiency (ARG1‐D) is an ultra‐rare urea cycle disorder characterized by progressive spastic paraplegia, developmental delay, epilepsy, and episodic hyperammonemia. Evidence on prevalence and clinical presentation is scarce. Therefore, epidemiology and the phenotypical spectrum were assessed in Germany, Austria, and Switzerland ...
Svenja Scharre +19 more
wiley +1 more source
Chicken Ornithine Transcarbamylase: Purification and Some Properties
Ornithine transcarbamylase [EC 2.1.3.3] has been purified from chick kidney to homogeneity. The molecular weight is 110,000 as determined by gel filtration.
Soichi Tsuji
core
Cryptogenic hepatitis masking the diagnosis of ornithine transcarbamylase deficiency
We describe three children with transaminase elevations and hepatic insufficiency who were given the diagnosis of cryptogenic hepatitis after the more common viral and metabolic diseases of the liver had been excluded.
Donati M. A. +3 more
core +1 more source
ABSTRACT In methylmalonic (MMA) and propionic acidemias (PA), liver or liver‐kidney transplantation (Tx) is indicated for metabolic decompensations, kidney failure (MMA), and to improve quality of life. Liver cancer was reported in five patients with MMA.
Léa Zloty +15 more
wiley +1 more source
Background Current understanding in arginine metabolism by streptococci is limited in species and strains.Objectives We compared the ability of several abundant oral streptococci to synthesize and assimilate arginine.Design Multiple species of oral ...
Lin Zeng
doaj +1 more source
Mutational spectrum and linkage disequilibrium patterns at the ornithine transcarbamylase gene (OTC)
Ornithine transcarbamylase (OTC; EC 2.1.3.3) is a hepatic enzyme involved in ammonia elimination via the urea cycle. Since the sequence of the OTC gene was reported many types of mutations continue to be found in OTC deficiency patients, continuing to ...
Diogo, L +10 more
core +1 more source

